Viridian Therapeutics, Inc. (VRDN) Tops Q1 EPS by 11c

Viridian Therapeutics, Inc. (NASDAQ: VRDN) reported Q1 EPS of ($0.87), $0.11 better than the analyst estimate of ($0.98). Revenue for the quarter came in at $70 thousand versus the consensus estimate of $52.09 thousand.

For earnings history and earnings-related data on Viridian Therapeutics, Inc. (VRDN) click here.

You May Also Be Interested In

• Reports Of Blasts Across Iran's Southern Regions: State TV - Bloomberg
• Science Applications (SAIC) PT Raised to $140 at Jefferies
• Gap taps Coach architect Reed Krakoff for $29.95-$498 handbag line